Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of SOX2 polyclonal antibody (A01)
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | ELISA,WB-Re |
More info about SOX2 polyclonal antibody (A01)
| Brand: | Abnova |
| Reference: | H00006657-A01 |
| Product name: | SOX2 polyclonal antibody (A01) |
| Product description: | Mouse polyclonal antibody raised against a full-length recombinant SOX2. |
| Gene id: | 6657 |
| Gene name: | SOX2 |
| Gene alias: | ANOP3|MCOPS3|MGC2413 |
| Gene description: | SRY (sex determining region Y)-box 2 |
| Genbank accession: | BC013923 |
| Immunogen: | SOX2 (AAH13923, 1 a.a. ~ 317 a.a) full-length recombinant protein with GST tag. |
| Immunogen sequence/protein sequence: | MYNMMETELKPPGPQQTSGGGGGNSTAAAAGGNQKNSPDRVKRPMNAFMVWSRGHRRKMAQENPKMHNSEISKRLGAEWKLLSETEKRPFIDEAKRLRALHMKEHPDYKYRPRRKTKTLMKKDKYTLPGGLLAPGGNSMASGVGVGAGLGAGVNQRMDSYAHMNGWSNGSYSMMQDQLGYPQHPGLNAHGAAQMQPMHRYDVSALQYNSMTSSQTYMNGSPTYSMSYSQQGTPGMALGSMGSVVKSEASSSPPVVTSSSHSRAPCQAGDLRDMISMYLPGAEVPEPAAPSRLHMSQHYQSGPVPGTAINGTLPLSHM |
| Protein accession: | AAH13923 |
| Storage buffer: | 50 % glycerol |
| Storage instruction: | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Recombinant Protein. |
| Quality control testing picture: |  |
| Quality control testing picture note: | Western Blot detection against Immunogen (60.98 KDa) . |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Applications: | ELISA,WB-Re |
| Shipping condition: | Dry Ice |
| Publications: | A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells.Esposito CL,Nuzzo S,Kumar SA,Rienzo A,Lawrence CL,Pallini R,Shaw L,Alder JE,Ricci-Vitiani L,Catuogno S,de Franciscisa V Journal of Controlled Release. 2016 Sep 28;238:43-57. |